Population structure of Leishmania infantum from Morocco  by Salsabil, H. et al.
trac
E
t
s
r
b
s
a
i
d
8
P
a
s
K
C
1
B
2
3
g
i
f
(
m
a
a
o
l
p
f
t
p
a
(
r
n
b
i
S
a
y
k
a
a
d
o
e
d14th International Congress on Infectious Diseases (ICID) Abs
infection, untreated Chagas’disease enters a chronic phase
that is initially asymptomatic or unrecognized. Between 20-
30% of patients develop cardiac abnormalities, 10% digestive
complaints, and less than 5% of patients develop a neurologic
form of disease. The aim of this work is to determiner the
effect of Benznidazol treatment (5mg/kg/day) 60 days, in
patients with chronic Chagas disease.
Methods: In 53 samples of patients we were tested
by enzyme linked immunoassay (ELISA Dade Behring
CHAGO560DB) for IgG antibodies against TC, and indirect
immunoﬂuorescence (IFI Biocientiﬁca SA Immunoﬂuor Cha-
gas NF09-60) as conﬁrmatory tes, for IgG (Bio-Merieux 75
692) antibodies, with serial serum dilutions to determine
the level of these antibodies. In addition, all PCR were per-
formed before treatment and at the end of it. As a criterion
of cure was established a signiﬁcant (more than 2 degrees)
in the rate of antibody after treatment.
Results: About the 53 patients studied, 37 were per-
formed two or more determinations of antibodies before
and after treatment and in 80% of them, a diminution of the
levels were found. The PCR was negative after treatment
in all cases. In 13 patients was carried out only antibody
titer before treatment, administering it even with low rates
from them, because they had organ involvement suggestive
of Chagas.
Conclusion: More studies are needed to clearly establish
the criteria for cure of Chagas disease.
Furthermore, because in these patients with chronic Cha-
gas disease parasitaemia sometimes is intermittent and low
have to question the result of a negative PCR.
doi:10.1016/j.ijid.2010.02.598
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Background: Visceral leishmaniasis (VL) is endemic in
northern Morocco where it is caused by Leishmania infan-
tum. It predominantly affects children under 4 years with
incidence of 100 cases/year. Genetic variability and popula-
tion structure has been investigated for 55 strains isolated
from infected dogs and humans in Morocco.
Methods: A multilocus microsatellite typing (MLMT)
approach was used in which a MLM type based on size varia-
tion in 14 independent microsatellite markers was compiled
for each strain. MLMT proﬁles of 21 European strains which
belonged to zymodeme MON-1 and non-MON1 according to
multilocus enzyme electrophoresis (MLEE) were included for
comparison.
Results: A Bayesian model-based approach and phylo-
genetic analysis based on genetic distances inferred two
populations of the Moroccan L. Infantum; population A con-
sists of 25 strains and population B consists of 30 strains.
Theses populations were signiﬁcantly different from the
T
o
its e441
uropean MON 1 and Non MON 1 strains which constructed
wo different populations respectively.
Gene ﬂow was noticed between populations A and B. Five
trains have shown mixed A B genotype indicating possible
ecombination between the two populations
Conclusion: No genetic differences were detected
etween parasites isolated from dogs and humans empha-
izing the role of dogs as reservoir. MLMT has proven to be
powerful tool for epidemiological and population genetic
nvestigations in Leishmani.
oi:10.1016/j.ijid.2010.02.599
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Background: One hundred years after its discovery, Cha-
as disease, caused by Trypanosoma cruzi, still represents an
mportant health problem and in need of alternative drugs
or the treatment of chagasic.
Methods: Ethanolic extract of Brazilian green propolis
Et-Bra) was assayed on amastigotes proliferation, trypo-
astigote by transmission and scanning electron microscopy
nd ﬂow cytometry. Thirty two 1,3,4-thiadiazole-2-
rilhyldrazones of megazol were synthesized and assayed
n trypomastigotes.
Results: Et-Bra was active against amastigotes pro-
iferation inside mammalian macrophages and induced
lasma membrane damage in the infective trypomastigote
orms as determined by transmission and scanning elec-
ron microscopy and ﬂow cytometry. In non-infected mice,
ropolis induced no toxicity as determined by the GPT, GOT
nd CK plasma levels. Treatment of T. cruzi-infected mice
up to 300mg Et-Bra/kg/day for 10 days) led to a signiﬁcant
eduction of the mortality but not of the parasitemia, did
ot reversed the hepatic, renal or muscular damage induced
y the parasite.
Themost active analogues in vitro -S1 to S8- were assayed
n vivo by a single oral dose at 5 dpi, being selected S1,
2 and S3, together with megazol for subsequent in vitro
nd in vivo studies. In trypomastigotes, ultrastructural anal-
sis revealed that the compounds led to alterations at
DNA, mitochondrion and ﬂagellar membrane and rounding
nd torsion of the parasite’s body. S1 and S2 inhibited the
mastigotes proliferation inside macrophages, while in car-
iac muscular cells only S1 was active. The administration
f 10 consecutive doses (50 and 100mg/kg) of S1 caused no
ffect on the course of infection, while S2 led to a signiﬁcant
ecrease of the parasitemia and S3, only of the mortality.
he three analogues were not toxic for the animals based
n the levels of GPT, GOT and urea.
Conclusion: Our results demonstrate the promising activ-
ty on T. cruzi, especially S2 and S3, justifying in vivo assays
